ITPC backs fight against replacement of HIV drug Dolutegravir in El Salvador
In El Salvador, people living with HIV are standing up against an unwanted change in the antiretroviral medication regimen.
Tag: dolutegravir
-
-
ICASA 2017 Reminds Us That the Fight for Optimal HIV Treatment is Far From Over
ABIDJAN, Côte d’Ivoire. December 8, 2017—A global network of activists is calling on pharmaceutical company ViiV Healthcare to allow people...
-
HIV Activists Denounce ViiV for Denying 3.5 million People Access to Optimal Treatment
Today, Monday, 24 July 2017, during the 9th International AIDS Conference on HIV Science in Paris (IAS 2017), HIV treatment...
-
Regional Spotlight: Catching Up with ITPC East Africa Regional Director Rose Kaberia
ITPC is an open and flexible coalition. Our eight regional ITPC networks form the backbone of our structure, leading the...
-
Brazil to use dolutegravir in first-line HIV treatment
"The recent announcement that dolutegravir is becoming part of the national HIV program in Brazil is great news for people living with HIV," Othoman Mellouk applauds civil society in Brazil.
-
Latest, most effective AIDS drugs not available in North Africa
Zakaria Bahtout, the Programs Partners’ Officer at ITPC MENA describes the protest targeting ViiV Healthcare, from the frontline in Harare, Zimbabwe, at...
-
Response to WHO HIV treatment guidelines
On World AIDS Day 2015, treatment activists highlight concerns about progress in response to consolidated WHO HIV treatment guidelines 2015.
-
Treatment advocates call on ViiV to allow access to dolutegravir
Today, at the International Conference on AIDS and STIs in Africa (ICASA), treatment advocates and activists from all over Africa...
